Lactate dehydrogenase, Catalase, and Superoxide dismutase in Tumor Tissue of Breast Cancer Patients in Respect to Mammographic Findings

Cell Biochemistry and Biophysics

Volumn 66, Issue 2, 2013, Pages 287-295

  Radenkovic, Sandra ^a   Milosevic, Zorica ^a,b   Konjevic, Gordana ^a,b   Karadzic, Katarina ^a   Rovcanin, Branislav ^b   Buta, Marko ^a   Gopcevic, Kristina ^b   Jurisic, Vladimir ^c  

^a INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c University of Kragujevac Medical Faculty   (Serbia)

Author keywords

Breast cancer; CAT; LDH; Mammographic characteristics; SOD

Indexed keywords

CATALASE; ISOPROTEIN; LACTATE DEHYDROGENASE; SUPEROXIDE DISMUTASE;

AGED; ARTICLE; BREAST TUMOR; CANCER STAGING; ENZYMOLOGY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAMMOGRAPHY; METABOLISM; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY;

AGED; BREAST NEOPLASMS; CATALASE; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; LYMPHATIC METASTASIS; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM STAGING; PROTEIN ISOFORMS; SUPEROXIDE DISMUTASE;

EID: 84878114292     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-012-9482-7     Document Type: Article

References (31)

1. Puliti, D., & Zappa, M. (2012). Breast cancer screening: are we seeing the benefit? BMC Medicne, 10, 106.
2. Boyd, N. F., Martin, L. J., Yaffe, M. J., & Minkin, S. (2011). Mammographic density and breast cancer risk: current understanding and future prospects. Breast Cancer Research, 13(6), 223.
3. Boyd, N. F., Melnichouk, O., Martin, L. J., Hislop, G., Chiarelli, A. M., Yaffe, M. J., et al. (2011). Mammographic density, response to hormones, and breast cancer risk. Journal of Clinical Oncology, 29(22), 2985-2992.
4. Boyd N. F. (2011) Tamoxifen, mammographic density, and breast cancer prevention. Journal of the National Cancer Institute, 103(9), 704-5.
5. Boyd, N. F., Martin, L. J., Bronskill, M., Yaffe, M. J., Duric, N., & Minkin, S. (2010). Breast tissue composition and susceptibility to breast cancer. Journal of the National Cancer Institute, 102(16), 1224-1237.
6. Boyd, N. F., & McGuire, V. (1990). Evidence of lipid peroxidation in premenopausal women with mammographic dysplasia. Cancer Letters, 50, 31-37.
7. Basu, A. K., & Marnett, L. J. (1983). Unequivocal demonstration that malondialdehyde is a mutagen. Carcinogenesis, 4, 331-333.
8. Jaganjac, M., Cacev, T., Cipak, A., Kapitanović, S., Gall Troselj, K., & Zarković, N. (2012). Even stressed cells are individuals: second messengers of free radicals in pathophysiology of cancer. Croatian Medical Journal, 53(4), 304-309.
9. Fantin, V. R., St-Pierre, J., & Leder, P. (2006). Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell, 9, 425-434.
10. Zhou, M., Zhao, Y., Ding, Y., Liu, H., Liu, Z., Fodstad, O., et al. (2010). Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol. Molecular Cancer, 9, 33.
11. Konjević, G., Spuzić, I., & Jurisić, V. (2001). Association of NK cell dysfunction with changes in LDH characteristics of peripheral blood lymphocytes (PBL) in breast cancer patients. Breast Cancer Research and Treatment, 66(3), 255-263.
12. De Berardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008). The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metabolism, 7, 11-20.
13. Ursin, G., Hovanessian-Larsen, L., Parisky, Y. R., Pike, M. C., & Wu, A. H. (2005). Greatly increased occurrence of breast cancers in areas of mammographically dense tissue. Breast Cancer Research, 7(5), 605-608.
14. Filipits, M., Rudas, M., Jakesz, R., Dubsky, P., Fitzal, F., Singer, C. F., et al. (2011). A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors. Clinical Cancer Research, 17(18), 6012-6020.
15. Wang, Y., Ikeda, D. M., Narasimhan, B., Longacre, T. A., Bleicher, R. J., Pal, S., et al. (2008). Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression. Radiology, 246(2), 367-375.
16. Stankovic, S., Konjevic, G., Gopcevic, K., Jovic, V., Inic, M., & Jurisic, V. (2010). Activity of MMP-2 and MMP-9 in sera of breast cancer patients. Pathology, Research and Practice, 206(4), 241-247.
17. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 1976(72), 248-254.
18. van der Helm, H. J. (1962). Interference of the measurement of lactate dehydrogenase (LDH) activity in human serum and plasma by LDH from blood cells. Clinica Chimica Acta, 1962(7), 124-128.
19. Cunningham, V. R., Phillips, J., & Field, E. J. (1965). Lactic dehydrogenase isoenzymes in normal and pathological spinal fluids. Journal of Clinical Pathology, 18(6), 765-770.
20. Weydert, C. J., & Cullen, J. J. (2010). Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue. Nature Protocols, 5(1), 51-66.
21. Burnside, E. S., Sickles, E. A., Bassett, L. W., Rubin, D. L., Lee, C. H., Ikeda, D. M., et al. (2009). The ACR BI-RADS experience: learning from history. Journal American College Radiology, 6(12), 851-860.
22. Boyd, N. F., Martin, L. J., Yaffe, M., & Minkin, S. (2009). Mammographic density. Breast Cancer Research, 11(3), S4.
23. Boyd, N. F., Rommens, J. M., Vogt, K., Lee, V., Hopper, J. L., Yaffe, M. J., et al. (2005). Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncology, 6(10), 798-808.
24. Fu, L., Tsuchiya, S., Matsuyama, I., & Ishii, K. (1998). Clinicopathologic features and incidence of invasive lobular carcinoma in Japanese women. Pathology International, 48, 348-354.
25. Seo, B. K., Pisano, E. D., Kuzimak, C. M., Koomen, M., Pavic, D., Lee, Y., et al. (2006). Correlation of HER-2/neu overexpression with mammography and age distribution in primary breast carcinomas. Academic Radiology, 13(10), 1211-1218.
26. Tabar, L., Tony Chen, H. H., Amy Yen, M. F., Tot, T., Tung, T. H., Chen, L. S. et al. (2004) Mammographic tumor features can predict long-term outcomes reliably in women with 1-14-mm invasive breast carcinoma. Cancer, 101(8), 1745-59.
27. Habel, L. A., Dignam, J. J., Land, S. R., Salane, M., Capra, A. M., & Julian, T. B. (2004). Mammographic density and breast cancer after ductal carcinoma in situ. Journal of the National Cancer Institute, 96, 1467-1472.
28. Dang, C. V., & Semenza, G. L. (1999). Oncogenic alterations of metabolism. Trends in Biochemical Sciences, 24(2), 68-72.
29. Hong, C. C., Tang, B. K., Rao, V., Agarwal, S., Martin, L., Tritchler, D., et al. (2004). Cytochrome P450 1A2 (CYP1A2) activity, mammographic density, and oxidative stress: a cross-sectional study. Breast Cancer Research, 6(4), R338-R351.
30. Tsanou, E., Ioachim, E., Briasoulis, E., Damala, K., Charchanti, A., Karavasilis, V., et al. (2004). Immunohistochemical expression of superoxide dismutase (MnSOD) anti-oxidant enzyme in invasive breast carcinoma. Histology and Histopathology, 19(3), 807-813.
31. Kattan, Z., Minig, V., Leroy, P., Dauça, M., & Becuwe, P. (2008). Role of manganese superoxide dismutase on growth and invasive properties of human estrogen-independent breast cancer cells. Breast Cancer Research and Treatment, 108(2), 203-215.